Wednesday, October 8, 2025

Time

Topic

Description/notes

7:30AM

Registration & Check-in

8AM

(5 min)

Welcome and Program Overview

Overview of program, today’s schedule, and how to access session materials (logistics, bathrooms, food and beverage, etc)

8:05AM

(30 min)

Regional Epidemiology

This session provides an overview of TB trends in the region, including case rates, risk factors, and emerging challenges.

8:35AM

(30 min)

TB Pathogenesis

This session explains how TB develops in the body, from infection to active disease, and addresses emerging topics in TB pathogenesis.

9:05AM

(30 min)

Clinical Diagnosis

This session covers the process of diagnosing TB, including common symptoms, clinical evaluations, and diagnostic tests.

9:35AM

(30 min)

Laboratory Diagnostics

This session explores the laboratory methods used to diagnose TB, including smear microscopy, culture, and molecular testing.

10:05AM

(15 min)

Break and Visit Exhibitors

10:20AM

(30 min)

Radiology

This session covers the role of radiology in TB diagnosis, focusing on chest X-ray findings and their interpretation.

10:50AM

(30 min)

Class 5 Tuberculosis

This session explains Class 5 TB, which refers to suspected but not yet confirmed TB cases.

11:20AM

(30 min)

Diagnosis Q&A Panel Discussion

11:50PM

(1hour 10min)

Lunch

TREATMENT BLOCK | SESSION CHAIR:

1PM

(30 min)

Treatment of LTBI

This session covers the treatment of latent TB infection (LTBI), including recommended regimens, patient monitoring, and strategies to improve adherence.

1:30PM

(30 min)

Treatment of Drug-Susceptible TB

This session focuses on the treatment of drug-susceptible TB, including the standard drug regimen, dosing, and duration.

2PM

(30 min)

Treatment of MDR

This session covers the treatment of multidrug-resistant TB (MDR-TB), including second-line drug regimens, duration of treatment, and managing complications.

2:30PM

(30 min)

Therapeutic Drug Monitoring

This session covers therapeutic drug monitoring in TB, focusing on how to assess drug levels and adjust treatment to ensure effectiveness.

3PM

(15 min)

Break and Visit Exhibitors

3:15PM

(30min)

Adverse Drug Reactions

This session focuses on recognizing and managing adverse drug reactions in TB treatment.

3:45PM

(45min)

Pulmonary Fascinomas with a TB Attitude

This session explores pulmonary fascinomas, a rare complication in TB patients, and how they are managed.  

4:30PM

(30 min)

Treatment Q&A Panel Discussion

5PM

Closing Remarks

5PM

Adjourn

Thursday, October 9, 2025

Time

Topic

Description and Objectives

7:30AM

Registration & Check-in

8:00AM

(5 min)

Welcome and Agenda Overview

Overview of today’s agenda and reminders to complete the course and faculty evaluation.

PEDIATRIC BLOCK | SESSION CHAIR:

8:05AM

(30 min)

Unique considerations in Pediatric Diagnosis

8:35AM

(30 min)

Unique considerations in Pediatric Treatment

This session focuses on the treatment of pediatric TB, covering age-specific drug dosages, formulations, and safety considerations.

9:05AM

(30 min)

Pediatric Case Presentation

9:35AM

(15 min)

Q&A Panel Discussion

9:50AM

(15 min)

Break and Visit Exhibitors

PUBLIC HEALTH | SESSION CHAIR:

10:05AM

(30 min)

Adherence Strategies, DOT, Incentives

This session focuses on adherence strategies for TB treatment, including Directly Observed Therapy (DOT) and the use of incentives.

10:35AM

(30 min)

Managing TB medication Doses, Side effects

This session focuses on dose counting in TB treatment, emphasizing how to track and ensure accurate medication dosing throughout the treatment course.

11:05AM

(30min)

Infectious period, & Isolation Guidelines

This session covers the infectious period in TB and the guidelines for patient isolation.

11:35AM

(30min)

TB Contact Investigations: Schools and Hospitals

This session discusses the processes, challenges, and outcomes of TB contact investigations in different settings, specifically schools and hospitals.

12:05PM

(15 min)

Public Health Q&A Panel Discussion

12:20PM

(1hour 10min)

Lunch

SPECIAL POPULATIONS BLOCK | SESSION CHAIR:

1:30PM

(30 min)

Diabetes

This session explores the relationship between diabetes and TB, focusing on how diabetes can impact TB diagnosis, treatment, and outcomes.

2PM

(30 min)

HIV

This session covers the intersection of HIV and TB, focusing on the increased risk of TB in individuals with HIV.

2:30PM

(30 min)

Mental Health

This session addresses the impact of mental health on TB treatment and outcomes.

3PM

(15 min)

Break and Visit Exhibitors

3:15PM

(30 min)

Immunomodulatory Biologics: Implications for Latent and Active Tuberculosis

This session explores the use of immunomodulatory biologics and their implications for latent and active TB.

3:45PM

(30 min)

Special Populations Q&A Panel Discussion

4:15PM

(15 min)

MCCT Resource Review

This session provides an overview of the MCCT resources, including educational offerings, mini fellowships, and medical consultation services.

4:30PM

Closing Remarks

Final session reminders and closing remarks

4:30PM

Adjourn